annb0t
Top 20
Recce Pharmaceuticals
Highlights:
Phase 1 safety and tolerability study of RECCE® 327 (R327) advancing to a Phase 1b/2a multi-dose and sepsis efficacy study Initiating two new Phase 2 trials of R327 for the treatment of urinary tract infections (UTIs) and diabetic foot ulcer (DFU) infections, respectively Multiple preclinical programs progressing to advanced stages
SYDNEY Australia, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company d...
>>> Read more: Recce Pharmaceuticals Announces Expansion and Acceleration of Clinical Programs
Highlights:
Phase 1 safety and tolerability study of RECCE® 327 (R327) advancing to a Phase 1b/2a multi-dose and sepsis efficacy study Initiating two new Phase 2 trials of R327 for the treatment of urinary tract infections (UTIs) and diabetic foot ulcer (DFU) infections, respectively Multiple preclinical programs progressing to advanced stages
SYDNEY Australia, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company d...
>>> Read more: Recce Pharmaceuticals Announces Expansion and Acceleration of Clinical Programs
